Speech-Language Pathologists in Columbia, IL Accepting Medicare

10 Speech-Language Pathologists found. Showing 1 - 10

Michelle Rogers Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2813 Robert Dr, Columbia, IL 62236 Phone: 314-471-6798

Mrs. Kristi K Bourisaw, MA CCC-SLP/L Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2627 Lakeshore Dr, Columbia, IL 62236 Phone: 636-565-4112    Fax: 636-590-9969

Stephanie Lynn Morris, MSCCC/SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 108 Gall Rd, Columbia, IL 62236 Phone: 618-606-0723

Tiny Voices Therapy Pc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2627 Lakeshore Dr, Columbia, IL 62236 Phone: 636-565-4112    Fax: 636-590-9969

Ms. Samantha M Schappaugh, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 100 Eagle Dr, Columbia, IL 62236 Phone: 309-215-5666

Mrs. Jan Marie Whitman, MA,CCC,SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1303 Palmer Creek Dr, Columbia, IL 62236 Phone: 618-281-2119

Haley Williams Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 105 North Riebeling Street, Columbia, IL 62236 Phone: 618-615-1784    Fax: 815-725-9993

Laura Lynn Maddin, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 113 S Rapp Ave, Columbia, IL 62236 Phone: 618-281-4995

Katelyn F Mushinsky, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 105 E Legion Ave, Columbia, IL 62236 Phone: 309-712-1024

Julia J. Hoffmann, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1021 Lexington Drive, Columbia, IL 62236 Phone: 314-221-1217

News Archive

Nevro to initiate Senza HF-SCS System study for chronic pain

Nevro Corp., a medical device company focused on achieving improved pain relief for patients suffering from debilitating chronic pain, today announced that the U.S. Food and Drug Administration (FDA) has granted approval for initiation of its SENZA-RCT study, a U.S. prospective, randomized, controlled pivotal clinical trial evaluating the safety and efficacy of Nevro's high-frequency spinal cord stimulation system for the treatment of chronic pain.

AMAG attributes increased second-quarter revenues of $18.8 million to Feraheme

AMAG Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia and novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease, today reported unaudited consolidated financial results for the second quarter and six months ended June 30, 2010. For the second quarter, AMAG reported total revenue of $18.8 million, including $16.0 million of Feraheme® (ferumoxytol) Injection for intravenous (IV) use net product revenues.

Mylan subsidiary receives FDA approval for Fludarabine Phosphate Injection ANDA

Mylan Inc. today announced that its subsidiary Bioniche Pharma received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Fludarabine Phosphate Injection USP, 25 mg/mL, packaged in 50 mg/2 mL Single-dose Vials. The product was determined to be bioequivalent and, therefore, therapeutically equivalent to Teva Parenteral's Fludarabine Phosphate Injection USP, 25 mg/mL, a chemotherapy medication for B-cell chronic lymphocytic leukemia (CLL).

Succes of pilot scheme means women in the UK will be offered abortions at home

Following a successful pilot scheme, women in the UK may soon be offered "home abortions".

Maternal MS not linked with poor pregnancy or birth outcomes

Canadian researchers have found that maternal multiple sclerosis (MS) is generally not associated with adverse delivery outcomes or risk to their offspring. Full findings now appear in Annals of Neurology, a journal published by Wiley-Blackwell on behalf of the American Neurological Association.

Read more Medical News

› Verified 6 days ago